Carlyle hires Goldman executive for China growth deals

Liu, who is based in Shanghai, spent 13 years with Goldman Sachs Principal Investment Area, latterly as a managing director. She has participated in investments such as Gan & Lee Pharmaceuticals, and Daesung Industrial Gases. Best Inc, a logistics provider backed by Alibaba Group, went public in the US last year, while Korea-based Daesung was sold to MBK Partners.

“We believe there are significant and exciting growth investment opportunities in China and across the region. With Wanlin joining us, we will continue to build on our leadership position investing in the growth space,” said X.D. Yang, managing director and chairman of Carlyle Asia, in a statement.

Carlyle established a presence in Asia in 1998 and now has nine offices in the region. From 1998 through to September 30, 2017, Carlyle has invested more than $14.7 billion of equity, and currently has $11.6 billion of assets under management in its Asian private equity platform.

As of September 2017, Carlyle had invested more than $7.5 billion of equity in over 90 transactions in China. The firm is currently raising its latest Asia buyout and growth funds. The former has a hard cap of $6.5 billion and reached a first close of $4.5 billion last October, while the latter has a target of $1 billion.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Greater China
• People
• China
• The Carlyle Group
• Appointments